Atlanta, Georgia; January 9th, 2026.
The CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) confirmed this week that it has begun acting on a presidential memorandum directing federal health agencies to review the national childhood immunization schedule, a move the agency says is being carried out through its established scientific and advisory framework, using the same procedural mechanisms that have governed immunization guidance for decades.
According to the CDC, the childhood immunization schedule, which serves as the national reference point for pediatric healthcare providers, public health departments, school systems, and other institutions across the country, is undergoing a formal evaluation as instructed by the memorandum. The agency stated that this review is focused on ensuring current recommendations reflect the most up-to-date scientific evidence, safety data, and public health information available, and that the work is proceeding within existing federal processes rather than through the creation of any new or ad hoc structures.
The CDC emphasized that the immunization schedule is not a fixed or permanent document, but one that has historically been reviewed and adjusted over time as new research emerges and disease patterns change. The agency noted that updates to the schedule are a routine part of public health oversight, though it acknowledged that this review is being conducted in direct response to presidential direction rather than as part of a regularly scheduled update cycle.
As outlined by the CDC, the review process includes internal scientific assessment as well as coordination with external advisory bodies, particularly the Advisory Committee on Immunization Practices, a federally chartered panel responsible for evaluating vaccine data and issuing recommendations that inform national guidance. The agency stated that this coordination remains central to how immunization policy is evaluated and maintained, and that the current review will follow the same standards of evidence and analysis applied in previous years.
At the time of the announcement, the CDC did not identify any specific vaccines, dosage schedules, or timing recommendations that are being targeted for change. Instead, the agency described the action as an evaluation process, clarifying that no immediate alterations to the existing childhood immunization schedule have been announced. Officials framed the effort as a review of guidance rather than an implementation of new policy.
The CDC reiterated that the childhood immunization schedule plays a central role in disease prevention efforts nationwide, providing a consistent framework for protecting children and adolescents from infectious diseases. The agency stated that maintaining scientifically grounded and evidence-based recommendations remains part of its core public health mission, and that the review is intended to ensure guidance continues to align with current data and public health needs.
In its statement, the CDC did not provide a timeline for when the review will be completed, nor did it outline potential outcomes or next steps beyond the evaluation itself. The agency indicated that additional information would be released if and when updates are finalized, consistent with its standard communication practices.
The announcement comes amid broader national discussions surrounding public health policy and federal oversight, though the CDC limited its statement to the scope of the memorandum and the technical review process now underway. No additional directives or enforcement actions were described in the release.
For now, the agency’s position remains procedural rather than prescriptive: a review has been initiated, established processes are being followed, and existing guidance remains in place pending the outcome of that evaluation.
Sources
Primary First-Hand Sources
- CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) — “CDC Acts on Presidential Memorandum to Update Childhood Immunization Schedule,” CDC Newsroom official release
Leave a Reply